EconomicGlobal
Insilico Medicine’s Alex Zhavoronkov bets China and AI can deliver the drug industry’s next breakthrough
Published:
News summary
AI drug discovery firm Insilico Medicine is profitable, publicly listed in Hong Kong, and running the drug industry's most consequential experiment.
- Importance
- Low · 23/100
- Impact direction
- Uncertain